Could a cannabis pill ease dangerous sleep apnea?
NCT ID NCT06477952
Summary
This study is testing whether a two-week course of dronabinol, a medication derived from cannabis, can reduce the severity of obstructive sleep apnea. It will involve about 120 veterans with moderate sleep apnea who will take the oral medication and have sleep studies before and after treatment. The goal is to see if the drug reduces breathing pauses during sleep and to identify which patients might benefit most from this potential new treatment option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jesse Brown VA Medical Center, Chicago, IL
RECRUITINGChicago, Illinois, 60612, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.